A H(a)rd Way to Adapt in Cardiac Hypertrophy
Haipeng Sun,Chen Gao,Yibin Wang
DOI: https://doi.org/10.1161/circresaha.115.307164
IF: 23.213
2015-01-01
Circulation Research
Abstract:HomeCirculation ResearchVol. 117, No. 6A H(a)rd Way to Adapt in Cardiac Hypertrophy Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBA H(a)rd Way to Adapt in Cardiac Hypertrophy Haipeng Sun, Chen Gao and Yibin Wang Haipeng SunHaipeng Sun From the Key Laboratory of Cell Differentiation and Apoptosis of Ministry of Education, Department of Pathophysiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China (H.S., Y.W.); and Division of Molecular Medicine, Departments of Anesthesiology, Medicine, and Physiology, David Geffen School of Medicine, University of California at Los Angeles (H.S., C.G., Y.W.). Search for more papers by this author , Chen GaoChen Gao From the Key Laboratory of Cell Differentiation and Apoptosis of Ministry of Education, Department of Pathophysiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China (H.S., Y.W.); and Division of Molecular Medicine, Departments of Anesthesiology, Medicine, and Physiology, David Geffen School of Medicine, University of California at Los Angeles (H.S., C.G., Y.W.). Search for more papers by this author and Yibin WangYibin Wang From the Key Laboratory of Cell Differentiation and Apoptosis of Ministry of Education, Department of Pathophysiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China (H.S., Y.W.); and Division of Molecular Medicine, Departments of Anesthesiology, Medicine, and Physiology, David Geffen School of Medicine, University of California at Los Angeles (H.S., C.G., Y.W.). Search for more papers by this author Originally published28 Aug 2015https://doi.org/10.1161/CIRCRESAHA.115.307164Circulation Research. 2015;117:484–486Heart is a highly regulated organ with remarkable abilities to adapt in response to physiological or pathological stresses.1 Cardiomyocyte hypertrophy and remodeling develop initially as compensatory steps to cope with increased hemodynamic load or loss of viable myocardium, whereas maladaptive changes contribute to transition to decompensation and overt heart failure. In the past decade, many biological processes have been uncovered to contribute to the initiation and progression of cardiac hypertrophy at molecular level, morphological level, and functional level.2–8 The complex network of stress response pathways in heart often serves as both culprits and potential therapeutic targets, and therefore uncovering these pathways has become a focus of intense investigation in the field of molecular cardiology.Article, see p 536Protein synthesis and quality control within endoplasmic reticulum (ER) are critical to cellular homeostasis and are tightly regulated by a highly conserved ER stress response signaling network9 (Figure). The outcome of the ER stress response includes attenuated de novo protein synthesis by protein kinase R-like endoplasmic reticulum kinase (PERK)–mediated inhibition of translation initiation,10 increased protein folding capacity via inositol-requiring enzyme 1 (IRE-1)/X-box binding protein 1 (Xbp-1)/activating transcription factor 6 (ATF-6)–mediated transcriptional activation of ER chaperone genes,11 such as binding immunoglobulin protein (BiP), and enhanced protein degradation capacity by ER-associated protein degradation (ERAD).12 This is an integrated and elegant feedback system to ensure that the cellular ER capacity matches with the dynamic changes in ER protein load. Although ER stress response functions as a compensatory and protective mechanism under physiological conditions, overactivation of the ER stress response can lead to pathological consequences. Indeed, excessive ER stress signaling has been implicated in a large number of human diseases affecting systems from neural immunity to metabolism.13,14 In the heart, ER stress induction is a common phenomena in stressed myocardium.15,16 Among the 3 downstream consequences of ER stress signaling, the cardioprotective effects of suppressing protein synthesis by protein kinase R-like endoplasmic reticulum kinase17 or enhancing ER protein folding capacity by Xbp-1/ATF-6/BiP18–20 against pathological remodeling have been demonstrated. In this issue, a report by Doroudgar et al21 has revealed the essential role of 3-hydroxy-3-methylglutaryl coenzyme A reductase degradation protein 1, or Hrd1, as an ER-targeted E3 ubiquitin ligase critical to ERAD in cardioprotection against pressure-overload–induced hypertrophy in heart. Thus, all 3 major downstream targets of ER stress signaling, including protein synthesis, folding capacity, and targeted degradation, have now been demonstrated to be critical to cardiac adaptation to stress.Download figureDownload PowerPointFigure. Illustration of adaptive ER stress pathways in cardiac hypertrophy. ATF-6 indicates activation transcription factor-6; Bip (also known as Grp78), binding immunoglobulin protein; ER, endoplasmic reticulum; ERAD, ER-associated protein degradation; Hrd1, 3-hydroxy-3-methylglutaryl coenzyme A reductase degradation protein 1; IRE-1, inositol-requiring enzyme 1; PERK, protein kinase R-like endoplasmic reticulum kinase; and Xbp-1, X-box binding protein 1.The current report by Doroudgar et al21 is an extension of a previous work in the laboratory of Glembotski, which showed the cardioprotective function of the ER stress regulator ATF-6 in the heart.22 This work led to the identification of the genes induced in ATF-6 transgenic hearts, including a known ERAD regulator Hrd1.23,24 In the current study,21 Hrd1 is shown to be a direct downstream target gene induced by ATF-6 and Xbp-1 in response to ER stress in cardiomyocytes. Using degradation of an exogenously introduced HA-tagged T-cell antigen receptor α-chain as a functional readout for the ERAD function, the authors report that Hrd1 induction is essential to augmented ERAD activity in the ER-stressed cardiomyocytes. Loss-of-function studies targeted to Hrd1 in vitro establish that Hrd1 expression is necessary for cardiomyocyte survival under ER stress. Remarkably, targeted suppression of Hrd1 expression in vivo exacerbates pathological remodeling and functional decompensation in pressure-overload heart. Therefore, Hrd1 expression is a critical component of ER stress response in cardiomyocytes with important cardioprotective function against pathological remodeling. More importantly, authors use adeno-associated virus 9-mediated gene transfer to achieve targeted Hrd1 expression in intact heart. Hrd1 overexpression significantly attenuates cardiac hypertrophy and preserves cardiac function against pressure overload. Taken together, this evidence suggests that Hrd1-mediated ERAD regulation is not only essential for compensatory adaptation in stressed heart but also can be potentially targeted to ameliorate pathological remodeling.Adaptation and maladaptation are key to understanding the critical transition from compensated hypertrophy to decompensated heart failure. Several studies, including the current report,21 have demonstrated that the signaling components involved in all aspects of ER stress pathways are indeed part of the cellular adaptation and maladaptation process in the stressed heart. ER capacity and flux seem to be a critical player in heart, where the resolution of ER stress can significantly affect the functional outcome under pathological stress. Although insufficient ER capacity can exacerbate cardiac pathology and heart failure, enhanced ER capacity attenuates pathological remodeling and dysfunction. It is known that misfolding of ER proteins can be induced not only by increased protein synthesis load but also by a variety of pathological changes, such as protein oxidation, post-translational modifications, and reduced proteasome capacity. Therefore, it would be a logical extension from the current study to demonstrate whether Hrd1-mediated ERAD can also affect the pathogenesis of heart failure under different causes in addition to mechanical overload, such as ischemic-reperfusion injury or chronic adrenergic stimulation. Furthermore, although enhancing ER capacity (by ATF-6/Xbp-1) or reducing ER load (by PERK or Hrd1) confers significant protection against pathological modeling in heart, it is not clear whether the underlying molecular mechanism is limited to the ER. It has been shown previously that ER stress signaling has broad impact on cell metabolism and gene regulation beyond the confines of ER modulation18,25,26; therefore, the cadioprotective mechanism may potentially involve not only more than the resolution of ER stress but also other cellular protective pathways in heart. Even more relevant to therapy, it would be critical to evaluate whether the maladaptive state of the ER stress can be reversed in heart by increasing ER capacity or reducing ER load. Targeted gene delivery using novel serotypes of AAV vectors as demonstrated in the current study or small molecules targeted to ER stress sensors27 can be implemented at different time points after the onset of pressure overload or different stages of pathological remodeling. The outcome of such investigation can help to put this question to the test: whether rebalancing ER homeostasis can block or even reverse the progression of pathological hypertrophy and dysfunction. In that regard, the study by Doroudgar et al21 is an exciting first step in a long journey to understand and conquer heart failure.Sources of FundingThis work was, in part, supported by Ministry of Science and Technology of China Grant 2012BAI02B05; National Institute of Health grantsHL108186, HL103205, HL098954, and HL080111 (to Dr Wang). American Heart Association (AHA) Western States Affiliate Post-doctoral Fellowship Award and AHA Science Development Grant (to H. Sun).FootnotesThe opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.Correspondence to Yibin Wang, PhD, 650 Charles E. Young Dr, Room CHS 569, Los Angeles, CA 90095. E-mail [email protected]References1. Hill JA, Olson EN. Cardiac plasticity.N Engl J Med. 2008; 358:1370–1380. doi: 10.1056/NEJMra072139.CrossrefMedlineGoogle Scholar2. Sciarretta S, Volpe M, Sadoshima J. Mammalian target of rapamycin signaling in cardiac physiology and disease.Circ Res. 2014; 114:549–564. doi: 10.1161/CIRCRESAHA.114.302022.LinkGoogle Scholar3. Ferrari R, Rizzo P. The Notch pathway: a novel target for myocardial remodelling therapy?Eur Heart J. 2014; 35:2140–2145. doi: 10.1093/eurheartj/ehu244.CrossrefMedlineGoogle Scholar4. Rose BA, Force T, Wang Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.Physiol Rev. 2010; 90:1507–1546. doi: 10.1152/physrev.00054.2009.CrossrefMedlineGoogle Scholar5. Olson EN. MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease.Sci Transl Med. 2014; 6:239ps3. doi: 10.1126/scitranslmed.3009008.CrossrefMedlineGoogle Scholar6. Steinberg SF. Cardiac actions of protein kinase C isoforms.Physiology (Bethesda). 2012; 27:130–139. doi: 10.1152/physiol.00009.2012.MedlineGoogle Scholar7. Dorn GW. Mitochondrial dynamism and heart disease: changing shape and shaping change.EMBO Mol Med. 2015; 7:865–877. doi: 10.15252/emmm.201404575.CrossrefMedlineGoogle Scholar8. Dorn GW. MicroRNAs: redefining mechanisms in cardiac disease.J Cardiovasc Pharmacol. 2010; 56:589–595. doi: 10.1097/FJC.0b013e3181f8d173.CrossrefMedlineGoogle Scholar9. Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation.Science. 2011; 334:1081–1086. doi: 10.1126/science.1209038.CrossrefMedlineGoogle Scholar10. Harding HP, Zhang Y, Bertolotti A, Zeng H, Ron D. Perk is essential for translational regulation and cell survival during the unfolded protein response.Mol Cell. 2000; 5:897–904.CrossrefMedlineGoogle Scholar11. Yamamoto K, Sato T, Matsui T, Sato M, Okada T, Yoshida H, Harada A, Mori K. Transcriptional induction of mammalian ER quality control proteins is mediated by single or combined action of ATF6alpha and XBP1.Dev Cell. 2007; 13:365–376. doi: 10.1016/j.devcel.2007.07.018.CrossrefMedlineGoogle Scholar12. Smith MH, Ploegh HL, Weissman JS. Road to ruin: targeting proteins for degradation in the endoplasmic reticulum.Science. 2011; 334:1086–1090. doi: 10.1126/science.1209235.CrossrefMedlineGoogle Scholar13. Lin JH, Walter P, Yen TS. Endoplasmic reticulum stress in disease pathogenesis.Annu Rev Pathol. 2008; 3:399–425. doi: 10.1146/annurev.pathmechdis.3.121806.151434.CrossrefMedlineGoogle Scholar14. Wang S, Kaufman RJ. The impact of the unfolded protein response on human disease.J Cell Biol. 2012; 197:857–867. doi: 10.1083/jcb.201110131.CrossrefMedlineGoogle Scholar15. Doroudgar S, Glembotski CC. New concepts of endoplasmic reticulum function in the heart: programmed to conserve.J Mol Cell Cardiol. 2013; 55:85–91. doi: 10.1016/j.yjmcc.2012.10.006.CrossrefMedlineGoogle Scholar16. Minamino T, Kitakaze M. ER stress in cardiovascular disease.J Mol Cell Cardiol. 2010; 48:1105–1110. doi: 10.1016/j.yjmcc.2009.10.026.CrossrefMedlineGoogle Scholar17. Liu X, Kwak D, Lu Z, Xu X, Fassett J, Wang H, Wei Y, Cavener DR, Hu X, Hall J, Bache RJ, Chen Y. Endoplasmic reticulum stress sensor protein kinase R-like endoplasmic reticulum kinase (PERK) protects against pressure overload-induced heart failure and lung remodeling.Hypertension. 2014; 64:738–744. doi: 10.1161/HYPERTENSIONAHA.114.03811.LinkGoogle Scholar18. Lynch JM, Maillet M, Vanhoutte D, et al. A thrombospondin-dependent pathway for a protective ER stress response.Cell. 2012; 149:1257–1268. doi: 10.1016/j.cell.2012.03.050.CrossrefMedlineGoogle Scholar19. Thuerauf DJ, Marcinko M, Belmont PJ, Glembotski CC. Effects of the isoform-specific characteristics of ATF6 alpha and ATF6 beta on endoplasmic reticulum stress response gene expression and cell viability.J Biol Chem. 2007; 282:22865–22878. doi: 10.1074/jbc.M701213200.CrossrefMedlineGoogle Scholar20. Martindale JJ, Fernandez R, Thuerauf D, Whittaker R, Gude N, Sussman MA, Glembotski CC. Endoplasmic reticulum stress gene induction and protection from ischemia/reperfusion injury in the hearts of transgenic mice with a tamoxifen-regulated form of ATF6.Circ Res. 2006; 98:1186–1193. doi: 10.1161/01.RES.0000220643.65941.8d.LinkGoogle Scholar21. Doroudgar S, Völkers M, Thuerauf DJ, Khan M, Mohsin S, Respress JL, Wang W, Gude N, Müller OJ, Wehrens XHT, Sussman MA, Glembotski CC. Hrd1 and ER-associated protein degradation, ERAD, are critical elements of the adaptive ER stress response in cardiac myocytes.Circ Res. 2015; 117:536–546. doi: 10.1161/CIRCRESAHA.115.306993.LinkGoogle Scholar22. Thuerauf DJ, Morrison LE, Hoover H, Glembotski CC. Coordination of ATF6-mediated transcription and ATF6 degradation by a domain that is shared with the viral transcription factor, VP16.J Biol Chem. 2002; 277:20734–20739. doi: 10.1074/jbc.M201749200.CrossrefMedlineGoogle Scholar23. Bordallo J, Plemper RK, Finger A, Wolf DH. Der3p/Hrd1p is required for endoplasmic reticulum-associated degradation of misfolded lumenal and integral membrane proteins.Mol Biol Cell. 1998; 9:209–222.CrossrefMedlineGoogle Scholar24. Kim H, Bhattacharya A, Qi L. Endoplasmic reticulum quality control in cancer: Friend or foe.Semin Cancer Biol. 2015CrossrefGoogle Scholar25. Wang ZV, Deng Y, Gao N, et al. Spliced X-box binding protein 1 couples the unfolded protein response to hexosamine biosynthetic pathway.Cell. 2014; 156:1179–1192. doi: 10.1016/j.cell.2014.01.014.CrossrefMedlineGoogle Scholar26. Aragón T, van Anken E, Pincus D, Serafimova IM, Korennykh AV, Rubio CA, Walter P. Messenger RNA targeting to endoplasmic reticulum stress signalling sites.Nature. 2009; 457:736–740. doi: 10.1038/nature07641.CrossrefMedlineGoogle Scholar27. Maly DJ, Papa FR. Druggable sensors of the unfolded protein response.Nat Chem Biol. 2014; 10:892–901. doi: 10.1038/nchembio.1664.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Abdulrahman N, Jaspard-Vinassa B, Fliegel L, Jabeen A, Riaz S, Gadeau A and Mraiche F (2018) Na + /H + exchanger isoform 1-induced osteopontin expression facilitates cardiac hypertrophy through p90 ribosomal S6 kinase , Physiological Genomics, 10.1152/physiolgenomics.00133.2017, 50:5, (332-342), Online publication date: 1-May-2018. Simpson L, Reader J and Tzima E (2020) Mechanical Regulation of Protein Translation in the Cardiovascular System, Frontiers in Cell and Developmental Biology, 10.3389/fcell.2020.00034, 8 August 28, 2015Vol 117, Issue 6 Advertisement Article InformationMetrics © 2015 American Heart Association, Inc.https://doi.org/10.1161/CIRCRESAHA.115.307164PMID: 26316602 Originally publishedAugust 28, 2015 Keywordshypertrophyprotein foldingheart failureERAD pathwayendoplasmic reticulum stressEditorialsPDF download Advertisement SubjectsCongenital Heart DiseaseHeart Failure